Brain injury after hypoxic-ischemic encephalopathy often develops with delayed appearance, opening a therapeutic window. Clinical studies in newborns show that post-hypoxic-ischemic hypothermia improves outcome. This has generated renewed interest in the molecular mechanisms of hypoxic-ischemic brain injury. In this brief review, we propose that mitochondrial permeabilization is crucial for injury to advance beyond the point of no return. We suggest that excitatory amino acids, nitric oxide, inflammation, trophic factor withdrawal, and an increased pro- versus antiapoptotic Bcl-2 protein ratio will trigger Bax-dependent mitochondrial outer membrane permeabilization. Mitochondrial outer membrane permeabilization, in turn, elicits mitochondrial release of cytochrome C, apoptosis-inducing factor, second mitochondria-derived activator of caspase/Diablo, and HtrA2/Omi. Cytochrome C efflux activates caspase-9/-3, leading to DNA fragmentation. Apoptosis-inducing factor interacts with cyclophilin A and induces chromatinolysis. Blockage of mitochondrial outer membrane permeabilization holds promise as a strategy for perinatal brain protection.
Jouvet P., Cowan FM, Cox P., et al. Reproducibility and accuracy of MR imaging of the brain after severe birth asphyxia. AJNR Am J Neuroradiol. 1999;20(7):1343-1348.
2.
Johnston MV, Hagberg H.Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol. 2007;49(1):74-78.
3.
Zhu C., Xu F., Wang X., et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem. 2006;96(4):1016-1027.
4.
Volpe JJBrain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol. 2009;8(1):110-124.
5.
Yang Z., Covey MV, Bitel CL, Ni L., Jonakait GM, Levison SWSustained neocortical neurogenesis after neonatal hypoxic/ ischemic injury . Ann Neurol.2007;61(3):199-208.
6.
Ito U., Spatz M., Walker JT Jr, Klatzo I.Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations. Acta Neuropathol. 1975;32(3):209-223.
7.
Suzuki R., Yamaguchi T., Kirino T., Orzi F., Klatzo I.The effects of 5-minute ischemia in Mongolian gerbils: I. Blood-brain barrier, cerebral blood flow, and local cerebral glucose utilization changes. Acta Neuropathol. 1983;60(3-4):207-216.
8.
Penrice J., Lorek A., Cady EB, et al. Proton magnetic resonance spectroscopy of the brain during acute hypoxia-ischemia and delayed cerebral energy failure in the newborn piglet . Pediatr Res. 1997;41(6):795-802.
9.
Gilland E., Bona E., Hagberg H.Temporal changes of regional glucose use, blood flow, and microtubule-associated protein 2 immunostaining after hypoxia-ischemia in the immature rat brain . J Cereb Blood Flow Metab. 1998;18(2):222-228.
10.
Azzopardi D. , Wyatt JS, Cady EB, et al. Prognosis of newborn infants with hypoxic-ischemic brain injury assessed by phosphorus magnetic resonance spectroscopy . Pediatr Res. 1989;25(5):445-451.
11.
Hanrahan D. , Cox IJ, Edwards AD, et al. Persistent increases in cerebral lactate concentration after birth asphyxia. Pediatr Res. 1998;44(3):304-311.
12.
Hanrahan D. , Cox IJ, Azzopardi D., et al. Relation between proton magnetic resonance spectroscopy within 18 hours of birth asphyxia and neurodevelopment at 1 year of age. Dev Med Child Neurol. 1999;41(2):76-82.
13.
Roth SC, Baudin J., Cady E., et al. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev Med Child Neurol. 1997;39(11):718-725.
14.
Hagberg H., Rousset CI, Wang X., Mallard C.Mechanisms of perinatal brain damage and protective possibilities. Drug Discovery Today: Disease Mechanisms. 2006;3(4):397-407.
15.
Gluckman PD , Wyatt JS, Azzopardi D., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005; 365(9460):663-670.
16.
Shankaran S. , Laptook AR, Ehrenkranz RA, et al;. National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med . 2005; 353(15):1574-1584.
17.
Johnston MVExcitotoxicity in perinatal brain injury. Brain Pathol. 2005;15(3):234-240.
18.
Ferriero DMNeonatal brain injury. N Engl J Med.2004; 351(19):1985-1995.
19.
Blomgren K. , Hagberg H.Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med.2006;40(3):388-397.
20.
Puka-Sundvall M., Gajkowska B., Cholewinski M., Blomgren K., Lazarewicz JW, Hagberg H.Subcellular distribution of calcium and ultrastructural changes after cerebral hypoxia-ischemia in immature rats. Dev Brain Res. 2000;125(1-2):31-41.
21.
Griffiths EJ , Halestrap APMitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J. 1995;307(pt 1):93-98.
Northington FJ, Ferriero DM, Flock DL, Martin LJDelayed neurodegeneration in neonatal rat thalamus after hypoxia-ischemia is apoptosis. J Neurosci. 2001;21(6):1931-1938.
24.
Gill R., Soriano M., Blomgren K., et al. Role of Caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J Cereb Blood Flow Metab. 2002;22(4): 420-430.
25.
Benjelloun N., Joly LM, Palmier B., Plotkine M., Charriaut-Marlangue C.Apoptotic mitochondrial pathway in neurones and astrocytes after neonatal hypoxia-ischaemia in the rat brain. Neuropathol Appl Neurobiol. 2003 ;29(4):350-360.
26.
Wang X., Zhu C., Hagberg H., et al. X-linked inhibitor of apoptosis (XIAP) protein protects against caspase activation and tissue loss after neonatal hypoxia-ischemia. Neurobiol Dis. 2004; 16(1):179-189.
27.
Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATPdependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997;91(4):479-489.
28.
Cheng Y., Deshmukh M., D’Costa A., et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest. 1998;101(9):1992-1999.
29.
Hu BR, Liu CL, Ouyang Y., Blomgren K., Siesjö BKInvolvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab. 2000; 20(9):1294-1300.
30.
Zhu C., Wang X., Hagberg H., Blomgren K.Correlation between caspase-3 activation and three different markers of DNA damage in neonatal cerebral hypoxia-ischemia. J Neurochem . 2000;75(2):819-829.
Hagberg H., Wilson MA, Matsushita H., et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem. 2004;90(5):1068-1075.
33.
Joly LM, Benjelloun N., Plotkine M., Charriaut-Marlangue C.Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat. Pediatr Res. 2003;53(5):776-782.
34.
Zhu C., Qiu L., Wang X., et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem. 2003;86(2):306-317.
35.
Zhu C., Wang X., Deinum J., et al. Cyclophilin A participates in the nuclear translocation of apoptosis inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med. 2007; 204(8):1741-1748.
36.
Ricci JE, Munoz-Pinedo C., Fitzgerald P., et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell. 2004;117(6):773-786.
37.
Zhu C., Wang X., Huang Z., et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ. 2007;14(4):775-784.
38.
Scorrano L., Nicolli A., Basso E., Petronilli V., Bernardi P.Two modes of activation of the permeability transition pore: the role of mitochondrial cyclophilin. Mol Cell Biochem. 1997;174(1-2): 181-184.
39.
Zamzami N., Larochette N., Kroemer G.Mitochondrial permeability transition in apoptosis and necrosis. Cell Death Differ. 2005;12(supp12):1478-1480.
40.
Zoratti M., Szabo I., De Marchi U.Mitochondrial permeability transitions: how many doors to the house? Biochim Biophys Acta. 2005;1706(1-2):40-52.
41.
Khaspekov L. , Friberg H., Halestrap A., Viktorov I., Wieloch T. Cyclosporin A and its nonimmunosuppressive analogue N-Me-Val-4-cyclosporin A mitigate glucose/oxygen deprivation-induced damage to rat cultured hippocampal neurons. Eur J Neurosci . 1999;11(9):3194-3198.
42.
Basso E., Fante L., Fowlkes J., Petronilli V., Forte MA, Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem. 2005 ;280(19): 18558-18561.
43.
Schinzel AC , Takeuchi O., Huang Z., et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA. 2005;102(34):12005-12010.
44.
Puka-Sundvall M., Gilland E., Hagberg H.Cerebral hypoxia-ischemia in immature rats: involvement of mitochondrial permeability transition? Dev Neurosci. 2001;23(3):192-197.
45.
Robertson CL , Bucci CJ, Fiskum G.Mitochondrial response to calcium in the developing brain. Dev Brain Res. 2004;151(1-2): 141-148.
46.
Wang X., Carlsson Y., Basso E., et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J Neurosci. 2009;29(8):2588-2596.
47.
Polster BM, Robertson CL, Bucci CJ, Suzuki M., Fiskum G.Postnatal brain development and neural cell differentiation modulate mitochondrial bax and BH3 peptide-induced cytochrome c release. Cell Death Differ.2003;10(3):365-370.
48.
Soane L., Siegel ZT, Shuh RA, Fiskum G.Postnatal developmental regulation of Bcl-2 family proteins in brain mitochondria . J Neurosci Res. 2008;86(6):1267-1276.
49.
Gibson ME, Han HH, Choi J., et al. Bax contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol Med. 2001;7(9):644-655.
50.
Youle RJ, Strasser A.The Bcl-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008; 9(1):47-59.
51.
Shimohama S. , Fujimoto S., Sumida Y., Tanino H.Differential expression of rat brain bcl-2 family proteins in development and aging. Biochem Biophys Res Commun. 1998;252(1):92-96.
52.
Parsadanian AS, Cheng Y., Keller-Peck CR, Holtzman DM, Snider WDBcl-xL is an antiapoptotic regulator for postnatal CNS neurons. J Neurosci. 1998;18(3):1009-1019.
53.
Ness JM, Harvey CA, Strasser A., Bouillet P., Klocke BJ, Roth KASelective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res. 2006;1099(1):150-159.
54.
Cheng Y., Gidday JM, Yan Q., Shah AR, Holtzman DMMarked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol . 1997;41(4):521-529.
55.
Han BH, D’Costa A., Back SA, et al. BDNF blocks caspase-3 activation in neonatal hypoxia-ischemia . Neurobiol Dis. 2000; 7(1):38-53.
56.
Brywe KG, Mallard C., Gustavsson M., et al. IGF-I neuroprotection in the immature brain after hypoxia-ischemia, involvement of Akt and GSK3beta?Eur J Neurosci.2005;21(6):1489-1502.
57.
Brywe KG, Leverin AL, Gustavsson M., et al. Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation . Endocrinology. 2005;146(11):4665-4672.
58.
Hagberg H., Gilland E., Diemer NH, Andiné P.Hypoxia-ischemia in the neonatal rat brain: histopathology after posttreatment with NMDA and non-NMDA receptor antagonists. Biol Neonate . 1994;66(4):205-213.
59.
Gilland E., Puka-Sundvall M., Hillered L., Hagberg H.Mitochondrial function and energy metabolism after hypoxia-ischemia in the immature rat brain: involvement of NMDA-receptors. J Cereb Blood Flow Metab. 1998;18(3):297-304.
60.
Puka-Sundvall M., Wallin C., Gilland E., et al. Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury. Dev Brain Res. 2000;125(1-2):43-50.
61.
Peeters-Scholte C., Koster J., Veldhuis W., et al. Neuroprotection by selective nitric oxide synthase inhibition at 24 hours after perinatal hypoxia-ischemia. Stroke. 2002;33(9):2304-2310.
62.
Hedtjärn M., Leverin AL, Eriksson K., Blomgren K., Mallard C., Hagberg H.Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci. 2002;22(14):5910-5919.
63.
Liu XH, Kwon D., Schielke GP, Yang GY, Silverstein FS, Barks JDMice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage. J Cereb Blood Flow Metab. 1999;19(10):1099-1108.
64.
Ten VS, Sosunov SA, Mazer SP, et al. C1q-deficiency is neuroprotective against hypoxic-ischemic brain injury in neonatal mice. Stroke. 2005;36(10):2244-2250.
65.
Martin D., Chinookoswong N., Miller G.The interleukin-1 receptor antagonist (rhIL-1ra) protects against cerebral infarction in a rat model of hypoxia-ischemia. Exp Neurol . 1994; 130(2):362-367.
66.
Liu XH, Eun BL, Barks JDPlatelet-activating factor antagonist BN 50730 attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res. 2001;49(6):804-811.
67.
Tsuji M., Higuchi Y., Shiraishi K., Kume T., Akaike A., Hattori H.Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr Res . 2000;47(1):79-83.
68.
Nijboer CH, Heijnen CJ, Groenendaal F., May MJ, van Bel F., Kavelaars A.Strong neuroprotection by inhibition of NFkappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke. 2008; 39(7):2129-2137.
